Amid the escalating mpox outbreak and the World Health Organization’s declaration of a public health emergency, South Korea-based Seegene has recently launched specialized research-use polymerase chain reaction (PCR) test assays.
Given the synergy between assay development and PCR system advancements, the South Korean PCR systems market is expected to grow at a compound annual growth rate (CAGR) of about 5% through 2033, according to GlobalData, a data and analytics company.
GlobalData’s Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 report reveals that South Korea accounts for around 6% of the Asia-Pacific PCR systems market in 2024.
“Introducing these specialized assays is in line with the key trends shaping the PCR systems market, which is experiencing significant growth driven by the increasing demand for accurate and rapid testing technologies. The focus on research and innovation in diagnostic solutions, particularly in the face of increasing infectious disease outbreaks, unlocks significant growth potential in addressing immediate public health challenges and paves the way for future innovations in healthcare diagnostics. Once commercialized, these devices will play a critical role in expanding access to advanced diagnostic capabilities,” Aditi Dakshesh Parikh, Medical Devices Analyst at GlobalData said in a statement.
The development of Seegene’s Novaplex Mpox PCR test assays, intended for research use, comes at a pivotal moment in the diagnostic landscape, as the world grapples with rising Mpox cases. It is a molecular diagnostic tool that leverages multiplex PCR technology to detect multiple pathogens caused by Orthopoxviruses, including Clades 1 and 2 of the Mpox virus. It also enables early differentiation of Mpox, which has a long incubation period of up to 21 days. Leveraging Seegene’s advanced Digitalized Development System (SGDDS), the assay offers high sensitivity and the ability to detect multiple genetic targets simultaneously.
“The ongoing development and integration of advanced PCR technologies are expected to meet the rising demands for high-throughput and sophisticated diagnostic solutions. This growth trajectory reflects a broader trend where enhanced PCR systems are becoming integral to improving diagnostic capabilities and addressing evolving global health challenges,” Parikh said.
